Michael Cannon
Angel · California
Board director at 2 startups that filed Form D raises since late 2024, mostly in California.
- Stages
- Seed, Series A
- Typical check (est.)
- Not disclosed
- Latest fund
- None on file
- Last verified activity
- Feb 2025
Focus
Biotech & PharmaRecent portfolio activity
Sources
- SEC Form D: Eureka TherapeuticsMay 17, 2023
- SEC Form D: Gleason TechnologyFeb 19, 2025
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.